Milan, Italy

Parini Ettore


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Milan, IT (1990 - 1991)
  • Cologno Monzese, IT (1991)

Company Filing History:


Years Active: 1990-1991

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Parini Ettore: Innovator in Pharmacological Compounds

Introduction

Parini Ettore is a notable inventor based in Milan, Italy, recognized for his contributions to the field of pharmacology. With a total of four patents to his name, he has made significant strides in developing novel compounds that exhibit promising therapeutic effects.

Latest Patents

Ettore's latest patents include innovative pharmacologically active piperidinylimidazopyridine compounds. These compounds are characterized by a specific formula wherein R represents an alkoxyalkyl radical containing 4 to 6 carbon atoms, an optionally substituted benzyl radical, or a tetrahydrofurfuryl radical. The compounds are noted for their antihistaminic and antiallergic activity, making them valuable in medical applications. Additionally, he has developed pharmacologically active aminoimidazopyridines, which are novel imidazopyridine derivatives. These derivatives also feature a specific formula where R can represent an alkoxyalkyl radical having 4-6 carbon atoms or a benzyl radical that may be substituted by a halogen atom.

Career Highlights

Ettore is currently employed at Dompe' Farmaceutici S.p.a., a company that focuses on pharmaceutical innovations. His work has contributed to the advancement of new therapeutic agents that address various health issues.

Collaborations

Throughout his career, Ettore has collaborated with esteemed colleagues, including Giani P Roberto and Borsa Massimiliano, who have also contributed to the field of pharmacology.

Conclusion

Parini Ettore's innovative work in pharmacological compounds highlights his significant role in advancing medical science. His patents reflect a commitment to developing effective therapeutic solutions that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…